Cancer Victim: Monsanto Is Liable Due To 'Wrongful Conduct' Regarding Glyphosate
MINNEAPOLIS - A cancer victim on Aug. 14 sued Monsanto Co. in Minnesota federal court, contending that exposure to glyphosate, the active ingredient in the company's herbicide Roundup, caused his T-cell lymphoma and that Monsanto is liable for "negligent and wrongful conduct" associated with the manufacture and distribution of the chemical (Clifford McCord v. Monsanto Company, No. 19-2252, D. Minn.). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - August 21, 2019 Category: Medical Law Source Type: news
Most diabetes patients unprepared for FDG-PET/CT scans
Many nuclear medicine practices are neglecting to tell patients with diabetes...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT aids in melanoma treatment assessment
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
FDG-PET/CT helps stage men with breast cancer, too
Prescan tutorial eases patient concerns about PET/CT
PET technique could aid diabetic therapy monitoring (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 11, 2019 Category: Radiology Source Type: news
Most diabetic patients unprepared for FDG-PET/CT scans
Many nuclear medicine practices are neglecting to tell diabetic patients that...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT aids in melanoma treatment assessment
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
FDG-PET/CT helps stage men with breast cancer, too
Prescan tutorial eases patient concerns about PET/CT
PET technique could aid diabetic therapy monitoring (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 10, 2019 Category: Radiology Source Type: news
HSCT in Advanced Stage Mycosis Fungoides and Sezary Syndrome HSCT in Advanced Stage Mycosis Fungoides and Sezary Syndrome
Is HSCT potentially curative for cutaneous T-cell lymphoma?Chinese Clinical Oncology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 29, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology Journal Article Source Type: news
City of Hope awarded $7.5 million to develop better treatment for a rare, incurable cancer
(City of Hope) City of Hope recently received $7.5 million to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma. The NCI awarded $6.3 million over five years to City of Hope's Steven Rosen, M.D., and Christiane Querfeld, M.D., Ph.D., so they can develop improved therapies for the disfiguring, incurable cancer that affects about 3,000 new individuals per year. LLS gave the pair two grants totaling $1.2 million over three years. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news
2 new PET tracers may best FDG in cancer imaging
Cancer detection could receive a boost from two new radiotracers that have...Read more on AuntMinnie.comRelated Reading:
Later PET/CT follow-up helps for oropharyngeal cancer
Ga-68 PSMA-11 PET/MRI improves prostate cancer detection
New PET tracer could aid melanoma detection
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
PET/CT predicts success of rad therapy for spinal mets (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2019 Category: Radiology Source Type: news
Later PET/CT follow-up helps for oropharyngeal cancer
Using PET/CT for follow-up at a later interval than what's recommended by existing...Read more on AuntMinnie.comRelated Reading:
FDG-PET/CT aids in melanoma treatment assessment
CT lung screening can catch recurring head, neck cancer
ASTRO: Blood test confirms HPV-related cancer remission
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
FDG-PET/CT helps stage men with breast cancer, too (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news
Book Review: Living Light: The Art of Using Light for Health & Happiness
While it’s hard not to notice the brilliant display of colors set off by a sunset over the water, we seldom consider the biological, or even psychological, benefits of light.
“It is my belief that good quality light in our daily lives is far more important than we might think,” writes Karl Ryberg.
In his new book, Living Light: The Art of Using Light For Health And Happiness, Ryberg brings us his life’s work — studying the obvious and not so obvious ways in which light affects us and how we can use light in our lives not only function better, but feel better.
Light, we know, plays an important role in seasona...
Source: Psych Central - March 10, 2019 Category: Psychiatry Authors: Claire Nana Tags: Book Reviews Disorders General Habits Psychology Seasonal Affective Disorder Self-Help Treatment artificial light Light therapy Living Light natural light Ryberg SAD Source Type: news
Antibody-Based Therapies for Cutaneous T-Cell Lymphoma Antibody-Based Therapies for Cutaneous T-Cell Lymphoma
Monoclonal antibody therapies, such as alemtuzumab, brentuximab vedotin, and mogamulizumab, are showing promise for previously relapsed and refractory CTCL.American Journal of Clinical Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 8, 2019 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
FDG-PET/CT aids in melanoma treatment assessment
Researchers have developed a new FDG-PET/CT-based approach to better monitor...Read more on AuntMinnie.comRelated Reading:
New PET tracer could aid melanoma detection
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
PET/CT predicts success of rad therapy for spinal mets
FDG-PET/CT helps stage men with breast cancer, too
PET/CT makes case for directing cervical cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 7, 2019 Category: Radiology Source Type: news
Caution urged for breast MRI evaluation of lymph nodes
VIENNA - How well can MRI diagnose axillary lymph node metastases in patients...Read more on AuntMinnie.comRelated Reading:
AI may predict lymph node metastasis in gastric cancer
FDG-PET/CT fails for peripheral T-cell lymphoma outcomes
PET/MRI falls short in lymph node metastases analysis
Midlevel image features help CAD find lymph nodes
PET/MRI tops DWI-MRI for head/neck lymph node metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 28, 2019 Category: Radiology Source Type: news
Aurora A kinase Inhibitor vs Standard Treatment for PTCL
Is Aurora A kinase inhibitor alisertib superior to standard treatment protocol for peripheral T-cell lymphoma? (Source: CancerNetwork)
Source: CancerNetwork - February 18, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news
Autologous Stem Cell Transplant May Aid Some With Nodal PTCL
WEDNESDAY, Feb. 13, 2019 -- Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study published online Jan. 29 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 13, 2019 Category: Pharmaceuticals Source Type: news
Breast Implant Link to Rare T-Cell Lymphoma an Ongoing Concern Breast Implant Link to Rare T-Cell Lymphoma an Ongoing Concern
Most confirmed cases have been associated with textured implants, which have been more popular in Europe than in the United States.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
$8 million grant pairs Wake Forest Baptist Health with 'Dream Team' fighting lymphoma
Wake Forest Baptist Health Comprehensive Cancer Center is one of four health systems from across the country to share in an $8 million grant from the American Association for Cancer Research.
The money is to be used to put together a “dream team” of doctors and researchers to develop therapies to better treat T-cell lymphoma, a rare cancer of the blood and immune system. T-cell lymphomas account for less than 15 percent of non-Hodgkin lymphomas in the U.S., according to the Amer ican Cancer… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - January 29, 2019 Category: Health Management Authors: John Joyce Source Type: news
